WEHI collaborates with Boehringer Ingelheim to develop novel anti-cancer therapeutics

By | June 25, 2021
WEHI has partnered with Boehringer Ingelheim, a leading research-driven pharmaceutical company, in a collaboration to discover and develop anti-cancer therapeutics using a promising new technology called targeted protein degradation.